The BRAF protein has become one of the major therapeutic targets in the treatment of both stage III and stage IV melanoma. The analysis of the BRAF mutational status has been established as a standard procedure during diagnosis of advanced malignant melanoma due to the fact that...
BRAF mutational status as a significant prognostic factor of OS
